pyrazolanthrone has been researched along with myristic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alarcón-Vila, C; Baulies, A; Caballeria, J; Casas, J; Elena, M; Fabriàs, G; Fernandez-Checa, JC; García-Ruiz, C; Martínez, L; Torres, S | 1 |
1 other study(ies) available for pyrazolanthrone and myristic acid
Article | Year |
---|---|
Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Topics: Animals; Anthracenes; Apoptosis; Ceramides; Cholesterol; Disease Models, Animal; Endoplasmic Reticulum Stress; Fatty Acids, Monounsaturated; Hepatocytes; JNK Mitogen-Activated Protein Kinases; Lipodystrophy; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Liver; Myristic Acid; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Oxidoreductases; Palmitic Acid; Protein Kinase Inhibitors; Reactive Oxygen Species; Ruthenium Red; Sphingosine N-Acyltransferase; Time Factors | 2015 |